Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist
Most Trending
-2.92%
-2.08%
+9.79%
-19.01%
-3.34%
EW
Edwards Lifesciences
$78.22
Chart
$69.2 (+13.03%)
$70.34 (+11.20%)
$68.93 (+13.48%)
$86.87 (-9.96%)
FIND US ON
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-2.92%
-2.08%
+9.79%
-19.01%
-3.34%
EW
Edwards Lifesciences
Current Price
$78.22
Login to view Edwards Lifesciences (EW) recommendation from the last 90 days from financial news and social media.
Chart
$69.2 (+13.03%)
$70.34 (+11.20%)
$68.93 (+13.48%)
$86.87 (-9.96%)
EW Latest Headlines
Edwards Lifesciences: Overbought Given Current Growth Prospects.
Today
Edwards Lifesciences stock rises following competitors exit.
Wed May 28, 2025
Assessing Edwards Lifesciences: Insights From 6 Financial Analysts. Edwards Lifesciences (NYSE:) has been analyzed by 6 analysts in the last three months revealing a diverse range of perspectives from ish to bearish.Summarizing their recent assessments the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.1230010000022000010000000Providing deeper insights analysts have established 12-month price targets indicating an average target of $
Thu May 22, 2025
Assessing Edwards Lifesciences: Insights From 6 Financial Analysts. Edwards Lifesciences (NYSE:) has been analyzed by 6 analysts in the last three months revealing a diverse range of perspectives from ish to bearish.Summarizing their recent assessments the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.1230010000022000010000000Providing deeper insights analysts have established 12-month price targets indicating an average target of $
Thu May 22, 2025
Should Edwards Lifesciences Stock Remain in Your Portfolio Now?. EW stock is on investors radars due to the promising structural heart opportunities and impressive TMTT portfolio.
Fri May 16, 2025
Should Edwards Lifesciences Stock Remain in Your Portfolio Now?. EW stock is on investors radars due to the promising structural heart opportunities and impressive TMTT portfolio.
Fri May 16, 2025
Do Wall Street Analysts Like Edwards Lifesciences Stock?. Despite Edwards Lifesciences underperformance relative to the broader market over the past year Wall Street analysts maintain a moderately optimistic outlook about the stocks prospects.
Wed May 14, 2025
Do Wall Street Analysts Like Edwards Lifesciences Stock?. Despite Edwards Lifesciences underperformance relative to the broader market over the past year Wall Street analysts maintain a moderately optimistic outlook about the stocks prospects.
Wed May 14, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
Hover over the category for more information
